This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

Summary

Pfizer Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Pfizer Inc. (Pfizer) is a research-driven biopharmaceutical company that focuses on the discovery, development, manufacturing, marketing, selling, and distribution of medicines and vaccines. Its products cover a broad spectrum of therapeutic areas, including anti-infectives, oncology, cardiovascular health, diabetes, obesity, inflammation, immunology, rare diseases, and bacterial infections. Pfizer also offers contract manufacturing services to other pharmaceutical companies. Healthcare providers, hospitals, clinics, and pharmacies utilize its products to manage various medical conditions. Pfizer distributes products through a network of wholesalers, retailers, and government agencies through brands such as Zavzpret, Abrysvo, Inflectra, Genotropin, Octagam, and ...

Table of Contents
Company Snapshot
AbbVie Inc.: Company Overview
AbbVie Inc.: Overview and Key Facts
AbbVie Inc.: Overview
AbbVie Inc.: Key Facts
AbbVie Inc.: Key Employees
AbbVie Inc.: Key Employee Biographies
AbbVie Inc.: Major Products and Services
AbbVie Inc.: Management Statement
AbbVie Inc.: Locations and Subsidiaries
AbbVie Inc.: Key Competitors
AbbVie Inc.: Company Analysis
AbbVie Inc.: Business Description
AbbVie Inc.: SWOT Analysis
AbbVie Inc.: SWOT Overview
AbbVie Inc.: Strengths
AbbVie Inc.: Weaknesses
AbbVie Inc.: Opportunities
AbbVie Inc.: Threats
AbbVie Inc.: Corporate Financial Deals Activity
AbbVie Inc.: Financial Deals Overview
AbbVie Inc.: Targets and Partners
AbbVie Inc.: Top Deals 2021 - 2025YTD*
AbbVie Inc.: Advisors
AbbVie Inc.: Top Legal Advisors
AbbVie Inc.: Top Financial Advisors
AbbVie Inc.: Mergers and Acquisitions
AbbVie Inc.: Corporate Venturing
AbbVie Inc.: Capital Raising
AbbVie Inc.: Partnership
AbbVie Inc.: Divestments
AbbVie Inc.: Recent Develop...

Summary

GSK plc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GSK plc. (GSK or 'the company'), formerly known GlaxoSmithKline plc, is a developer, manufacturer, and marketer of vaccines, pharmaceuticals, over the counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, FluLaval, Bexsero, Menveo, Polident, Boostrix, Priorix, Otrivin, Theraflu, Aquafresh, and Imitrex brand names. It merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. GSK has a business presence across the Americas, the Middle East, Africa, A...

Summary

F. Hoffmann-La Roche Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

F. Hoffmann-La Roche Ltd (Roche or 'the company') is a healthcare company that develops and commercializes innovative therapeutic and diagnostic products. The company researches and manufactures pharmaceutical products in various therapeutic areas, such as oncology, immunology, ophthalmology, infectious diseases, and neuroscience. It also offers immunoassays, clinical chemistry and laboratory automation, disease management, software solutions and digital solutions, patient self-testing products, and urinalysis products. Additionally, the company specializes in tissue-based cancer diagnostics, in vitro diagnostics, and diabetes management. Roche provides its products and services to commercial diagnostic laboratories, hospitals, pharmacists...

Summary

A Menarini Industrie Farmaceutiche Riunite Srl - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

A Menarini Industrie Farmaceutiche Riunite Srl (Menarini or 'the company'), a pharmaceutical business entity. The company is involved in the development and manufacture of pharmaceutical products mainly for cardiovascular diseases; gastro-intestinal; Analgesia; gastrointestinal disorders; reumatology / osteoporosis; allergology; andrology; antinfective area; oncology; pain; inflammation; gynecology and women's wellness; dermatology and personal care; and asthma. Its manufacturing facilities and research and development centers are located in Pisa, Pomezia, Castel Maggiore and Firenze. Menarini markets its products through distributors and local partners. The company operates in Eastern and Central Europe, Central...

Summary

PAREXEL International Corporation - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PAREXEL International Corporation (PAREXEL or 'the company') is a leading global biopharmaceutical services provider. The company's service portfolio include building patient insights into assets, profile, and claims, portfolio optimization, asset valuation and, indication prioritization, model-based drug development, integrated development strategy and planning, patient engagement strategy and enrollment solutions, protocol optimization, clinical trial, supply and logistics and medical communications services, among others. The company provides its products and services to pharmaceutical, biotechnology and medical device industries across the world. PAREXEL operates in North America, Latin America, Europe, Asia-Pacific, the ...

Summary

PharMerica Corporation - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PharMerica Corporation (PharMerica or 'the company') is a pharmacy management services provider for skilled nursing facilities (SNF), long term care facilities (LTC), assisted living facilities (ALF), hospitals and other institutional care settings. It offers onsite pharmacy services, pharmacist services, reporting, order notifications, paper medical record, electronic medical recording, transitional care services, customer services, and living pharmacy. The company offers world-class pharmacy services including long-term and post-acute facilities, behavioral health solutions, senior and independent living, home infusion, specialty pharmacy and hospice. Apart from these, it offers discharge assistance and medication packing services. The com...

Summary

Bayer AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bayer AG (Bayer or 'the group') is a life science company that develops pharmaceutical, and chemical products. The company offers prescription and non-prescription medical products, cosmetics, seeds, plant traits, chemical, and biological crop protection products. It also offers products and solutions for the prevention and treatment of diseases in companion and farm animals. The company markets its products under various brands including Adalat, Redoxon, Baytril, Xofigo, Nativo, Serenade, Canesten, Afrin, Cydectin and Seresto brand names. Bayer distributes its products directly to farmers and through pharmacies, retailers, wholesalers, hospitals, veterinarians, supermarkets and drugstore chains. It has business presence in the Asia Pacific, Europe, North...

This new report provides analysis of Elanco/Bayer’s capabilities, goals and strategies in the global animal health market, including:

- Strong technological base - Fermentation and chemical synthesis - Strong base in antibiotics and anticoccidials - Expiration of patents caused restructuring - US marketing - Lilly Japan - Focused marketing strategies - Well-established relationship with customers - Multi-disciplinary business with diverse product portfolio - In the midst of strategic decisions - Stepping up efforts to curtail time to market - Could divest animal health - Changed product mix - Strategic collaborations - Broadening portfolio of companion animal medicines - Hard look at bottom line - CEO Dave Ricks ...

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

Strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability.

This new report from VPG provides strategic assessment of Elanco/Bayer's technological know-how, marketing tactics and strategic directions in the global animal health market.

Technological Know-How

- Internally developed and acquired animal health technologies, processes and related capabilities.

- Proprietary technologies and patent litigations.

Marketing Tactics

- Sales force size in the U.S. and other markets.

- Promotional tactics.

- Distribution approaches.

- Product service and support.

- Customer relations

Strategic Direction

- Specific business, new product development and marketing strategies.

- Anticipated acquisitions, joint ventures and divestitures.

- Major strengths and weaknesses.

This new report provides analysis of Elanco/Bayer’s capabilities, goals and strategies in the global animal health market, including:

- Considering selling animal health division - Plans to invest in Kiel - Rising demand for collars - Focusing on parasiticides and anti-infectives - Strong position in parasiticides - Animal health R&D - Worldwide marketing network - Emerging markets - Re-registering existing products - Present structure - Diverse businesses - Challenged by animal disease outbreaks - Europe's premier research organization - Animal health R&D - Crop science segment - Monsanto acquisition - Chairman Werner Baumann - Supervisory board

The report also provides assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and includ...

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.